Nucleotide sequence context influences HIV replication fidelity by modulating reverse transcriptase binding and product release

BioScience Trends

Volumn 1, Issue 1, 2007, Pages 52-61

  Yamanaka, Rio ^a   Termini, John ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Polymerase; Reverse transcriptase; RNase H; Sequence context; Steady and presteady and state kinetics

Indexed keywords

PRIMER DNA; REVERSE TRANSCRIPTASE, HUMAN IMMUNODEFICIENCY VIRUS 1; RIBONUCLEASE H; RNA DIRECTED DNA POLYMERASE;

ARTICLE; CHEMISTRY; GENETICS; KINETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROTEIN BINDING; PROTEIN SECONDARY STRUCTURE; VIRUS REPLICATION;

BASE SEQUENCE; DNA PRIMERS; HIV REVERSE TRANSCRIPTASE; KINETICS; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; RIBONUCLEASE H; VIRUS REPLICATION;

EID: 77952304889     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Roberts JD, Bebenek K, Kunkel TA. The accuracy of reverse transcriptase from HIV-1. Science 1988;242:1171-1173.
2. Ji J, Loeb LA. Fidelity of HIV-1 reverse transcriptase copying a hypervariable region of the HIV-1 env gene. Virology 1994;199:323-330.
3. Preston BD, Poiesz BJ, Loeb LA. Fidelity of HIV-1 reverse transcriptase. Science 1988;242:1168-1171.
4. Mansky LM, Temin HM. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 1995;69:5087-5094.
5. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996;271:1582-1586.
6. Bebenek K, Abbotts J, Wilson SH, Kunkel TA. Errorprone polymerization by HIV-1 reverse transcriptase. Contribution of template-primer misalignment, miscoding, and termination probability to mutational hot spots. J Biol Chem 1993;268:10324-10334.
7. Abbotts J, Bebenek K, Kunkel TA, Wilson SH. Mechanism of HIV-1 reverse transcriptase. Termination of processive synthesis on a natural DNA template is infl uenced by the sequence of the template-primer stem. J Biol Chem 1993;268:10312-10323.
8. Suo Z, Johnson KA. Effect of RNA secondary structure on the kinetics of DNA synthesis catalyzed by HIV-1 reverse transcriptase. Biochemistry 1997;36:12459-12467.
9. Suo Z, Johnson KA. RNA secondary structure switching during DNA synthesis catalyzed by HIV-1 reverse transcriptase. Biochemistry 1997;36:14778-14785.
10. Ji X, Klarmann GJ, Preston BD. Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro. Biochemistry 1996;35:132-143.
11. Wu W, Henderson LE, Copeland TD, Gorelick R J, Bosche WJ, Rein A, Levin J G. Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract. J Virol 1996;70:7132-7142.
12. Lapadat-Tapolsky M, Gabus C, Rau M, Darlix JL. Possible roles of HIV-1 nucleocapsid protein in the specificity of proviral DNA synthesis and in its variability. J Mol Biol 1997;268:250-260.
13. Jaruga P, Jaruga B, Olczak A, Halota W, Olinski R. Oxidative DNA base damage in lymphocytes of HIVinfected drug users. Free Radic Res 1999;31:197-200.
14. Valentine MR, Termini J. Kinetics of formation of hypoxanthine containing base pairs by HIV-RT: RNA template effects on the base substitution frequencies. Nucleic Acids Res 2001;29:1191-1199.
15. Wuenschell GE, Valentine MR, Termini J. Incorporation of oxidatively modifi ed 2'-deoxynucleotide triphosphates by HIV-1 RT on RNA and DNA templates. Chem Res Toxicol 2002;15:654-661.
16. Klarmann GJ, Smith RA, Schinazi RF, North TW, Preston BD. Site-specific incorporation of nucleoside analogs by HIV-1 reverse transcriptase and the template grip mutant P157S. Template interactions influence substrate recognition at the polymerase active site. J Biol Chem 2000;275:359-366.
17. Boyer PL, Tantillo C, Jacobo-Molina A, Nanni RG, Ding J, Arnold E, Hughes SH. Sensitivity of wildtype human immunodeficiency virus type 1 reverse transcriptase to dideoxynucleotides depends on template length; the sensitivity of drug-resistant mutants does not. Proc Natl Acad Sci U S A 1994;91:4882-4886.
18. Ding J, Hughes SH, Arnold E. Protein-nucleic acid interactions and DNA conformation in a complex of human immunodeficiency virus type 1 reverse transcriptase with a double-stranded DNA templateprimer. Biopolymers 1997;44:125-138.
19. Huang H, Chopra R, Verdine GL, Harrison SC. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science 1998;282:1669-1675.
20. Sarafianos SG, Das K, Tantillo C, Clark AD, Jr. Ding J, Whitcomb JM, Boyer PL, Hughes SH, Arnold E. Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA. Embo J 2001;20:1449-1461.
21. Beard WA, Bebenek K, Darden TA, Li L, Prasad R, Kunkel TA, Wilson SH. Vertical-scanning mutagenesis of a critical tryptophan in the minor groove binding track of HIV-1 reverse transcriptase. Molecular nature of polymerase-nucleic acid interactions. J Biol Chem 1998;273:30435-30442.
22. Bebenek K, Beard WA, Darden TA, Li L, Prasad R, Luton BA, Gorenstein DG, Wilson SH, Kunkel TA. A minor groove binding track in reverse transcriptase. Nat Struct Biol 1997;4:194-197.
23. Sevilya Z, Loya S, Duvshani A, Adir N, Hizi A. Mutagenesis of cysteine 280 of the reverse transcriptase of human immunodefi ciency virus type-1: the effects on the ribonuclease H activity. J Mol Biol 2003;327:19-30.
24. Starcich BR, Hahn BH, Shaw GM, McNeely PD, Modrow S, Wolf H, Parks ES, Parks WP, Josephs SF, Gallo RC, Wong-Staal F. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell 1986;45:637-648.
25. Borer PN. In Fassman GD. (ed.), Handbook of Biochemistry and Molecular Biology, 3rd Edition. CRC Press, Cleveland, OH, Vol. 1, pp. 589-595, 1975.
26. Johnson KA. Rapid quench kinetic analysis of polymerases, adenosinetriphosphatases, and enzyme intermediates. Methods Enzymol 1995;249:38-61.
27. Klarmann GJ, Hawkins ME, Le Grice SF. Uncovering the complexities of retroviral ribonuclease H reveals its potential as a therapeutic target. AIDS Rev 2002;4:183-194.
28. Kati WM, Johnson KA, Jerva LF, Anderson KS. Mechanism and fi delity of HIV reverse transcriptase. J Biol Chem 1992;267:25988-25997.
29. Hsieh JC, Zinnen S, Modrich P. Kinetic mechanism of the DNA-dependent DNA polymerase activity of human immunodeficiency virus reverse transcriptase. J Biol Chem 1993;268:24607-24613.
30. Weiss KK, Chen R, Skasko M, Reynolds HM, Lee K, Bambara RA, Mansky LM, Kim B. A role for dNTP binding of human immunodeficiency virus type 1 reverse transcriptase in viral mutagenesis. Biochemistry 2004;43:4490-4500.
31. Suo Z, Johnson KA. Effect of RNA secondary structure on RNA cleavage catalyzed by HIV-1 reverse transcriptase. Biochemistry 1997;36:12468-12476.
32. Gopalakrishnan V, Peliska JA, Benkovic SJ. Human immunodeficiency virus type 1 reverse transcriptase: spatial and temporal relationship between the polymerase and RNase H activities. Proc Natl Acad Sci U S A 1992;89:10763-10767.
33. Jacobo-Molina A, Ding J, Nanni RG, Clark Jr. AD, Lu X, Tantillo C, Williams RL, Kamer G, Ferris AL, Clark P, Hizi A, Hughesi SH, Arnold E. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc Natl Acad Sci U S A 1993;90:6320-6324.
34. Fersht AR. Catalysis, binding and enzyme-substrate complementarity. Proc R Soc Lond B Biol Sci 1974;187:397-407.
35. Boosalis MS, Petruska J, Goodman MF. DNA polymerase insertion fi delity. Gel assay for site-specifi c kinetics. J Biol Chem 1987;262:14689-14696.